Publications (11)

¹ Publicaciones consideradas como producción del grupo

filter_list Physiology

2025

  1. Analysis of key proinflammatory mechanisms in cardiovascular pathology through stimulation with lipopolysaccharide and urban particulate matter in mouse atrial cardiomyocytes

    Environmental Toxicology and Pharmacology, Vol. 114

2024

  1. Hypertrophic cardiomyopathy due to truncating variants in myosin binding protein C: A Spanish cohort

    Open Heart, Vol. 11, Núm. 2

  2. Potential Impact of Bioactive Peptides from Foods in the Treatment of Hypertension

    Molecular Nutrition and Food Research, Vol. 68, Núm. 14

  3. Upregulation of NOR-1 in calcified human vascular tissues: impact on osteogenic differentiation and calcification

    Translational Research, Vol. 264, pp. 1-14

2023

  1. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53

  2. Current therapies for hypertrophic cardiomyopathy: a systematic review and meta-analysis of the literature

    ESC Heart Failure, Vol. 10, Núm. 1, pp. 8-23

2022

  1. Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2170-2180

2021

  1. The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Connexin 43 deficiency is associated with reduced myocardial scar size and attenuated tgfβ1 signaling after transient coronary occlusion in conditional knock-out mice

    Biomolecules, Vol. 10, Núm. 4

  2. Pilot study on the role of circulating mirnas for the improvement of the predictive ability of the 2mace score in patients with atrial fibrillation

    Journal of Clinical Medicine, Vol. 9, Núm. 11, pp. 1-11

  3. Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry

    Annals of Medicine, Vol. 52, Núm. 6, pp. 300-309